The Lyme Disease Diagnostics Market is estimated to be valued at US$ 837.2 million in 2022 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 - 2030.
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |